[HTML][HTML] HIV drug resistance—an emerging threat to epidemic control
C Beyrer, A Pozniak - New England Journal of Medicine, 2017 - Mass Medical Soc
C Beyrer, A Pozniak
New England Journal of Medicine, 2017•Mass Medical SocHIV Drug Resistance — An Emerging Threat to Epidemic Control | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
An estimated 19.5 million HIV-infected people worldwide are now receiving antiretroviral therapy, and treatment programs have had substantial effects on the rate of new infections. But the emergence of HIV drug resistance is a very real threat to these gains.
The New England Journal Of Medicine